Marc Mirande
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Marc Mirande has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Fawzi Khoder-Agha
Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark
3 shared publications Martine Comisso
Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette, France
3 shared publications- José Dias
Institut de Recherche Biomédicale des Armées
2 shared publications Alice Hadchouel
Service de Pneumologie et d'Allergologie Pédiatriques, AP-HP, Hôpital Universitaire Necker-Enfants Malades, Paris, France
1 shared publicationAzaria Rémion
Laboratoire d'Enzymologie et Biochimie Structurales (LEBS) CNRS Gif-sur-Yvette France
1 shared publication- Boris S. Negrutskii
Institute of Molecular Biology and Genetics, NAS of Ukraine Department of Structural and Functional Proteomics Kyiv 03143
1 shared publication
Latest Publications
- Open Access
- 12 November 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (11) , e0208725
Inhibition of HIV-1 replication by primer RNA packaging inhibitors
An essential step in the life cycle of human immunodeficiency virus type 1 (HIV-1) is the packaging of tRNA 3 Lys during viral assembly. This step, which requires the assembly of a ternary complex consisting of GagPol, mitochondrial lysyl-tRNA synthetase, and tRNA 3 Lys , is essential for the production of infectious viruses. Indeed, it allows the initiation of reverse transcription in the particles. In this work, we used an in vitro assay to isolate molecules from a chemical library that disrupt the interaction between the integrase domain of GagPol and mitochondrial lysyl-tRNA synthetase. The three selected molecules also inhibit HIV-1 replication in an ex vivo assay. The number of HIV-1 particles produced in the presence of the drugs is greatly reduced, with a half-maximal inhibitory concentration obtained at a drug concentration of 5 µM. In addition, we have shown that the few particles produced in the presence of the drugs exhibit significantly reduced infectivity, due to their inability to synthesize minus-strand strong stop cDNA. In parallel, the tRNA 3 Lys content of the particles obtained in the presence of drugs decreased significantly. The inability to package tRNA 3 Lys into virions results in replication-defective particles. IMPORTANCE: Several families of inhibitors have been selected to tackle the human immunodeficiency virus (HIV). Cell entry, reverse transcriptase, integrase, or protease is the most popular targets along the viral life cycle. During the budding step of the virus, the packaging of tRNA 3 Lys into particles, which serves as a primer for the initiation of reverse transcription in the virus, has been shown to be essential for the production of infectious virions. In this study, we isolated molecules that inhibit viral replication by inhibiting the incorporation of tRNA 3 Lys into virions. The inhibitors of HIV-1 replication described in this work demonstrate that the HIV-1 tRNA packaging step can be exploited for the development of a new family of drugs with novel resistance profiles.
- 12 November 2025
- Published by American Society for Microbiology in mBio
- Vol. 16 (11) , e0208725
Open AccessInhibition of HIV-1 replication by primer RNA packaging inhibitors
An essential step in the life cycle of human immunodeficiency virus type 1 (HIV-1) is the packaging of tRNA 3 Lys during viral assembly. This step, which requires the assembly of a ternary complex consisting of GagPol, mitochondrial lysyl-tRNA synthetase, and tRNA 3 Lys , is essential for the production of infectious viruses. Indeed, it allows the initiation of reverse transcription in the particles. In this work, we used an in vitro assay to isolate molecules from a chemical library that disrupt the interaction between the integrase domain of GagPol and mitochondrial lysyl-tRNA synthetase. The three selected molecules also inhibit HIV-1 replication in an ex vivo assay. The number of HIV-1 particles produced in the presence of the drugs is greatly reduced, with a half-maximal inhibitory concentration obtained at a drug concentration of 5 µM. In addition, we have shown that the few particles produced in the presence of the drugs exhibit significantly reduced infectivity, due to their inability to synthesize minus-strand strong stop cDNA. In parallel, the tRNA 3 Lys content of the particles obtained in the presence of drugs decreased significantly. The inability to package tRNA 3 Lys into virions results in replication-defective particles. IMPORTANCE: Several families of inhibitors have been selected to tackle the human immunodeficiency virus (HIV). Cell entry, reverse transcriptase, integrase, or protease is the most popular targets along the viral life cycle. During the budding step of the virus, the packaging of tRNA 3 Lys into particles, which serves as a primer for the initiation of reverse transcription in the virus, has been shown to be essential for the production of infectious virions. In this study, we isolated molecules that inhibit viral replication by inhibiting the incorporation of tRNA 3 Lys into virions. The inhibitors of HIV-1 replication described in this work demonstrate that the HIV-1 tRNA packaging step can be exploited for the development of a new family of drugs with novel resistance profiles.
- Open Access
How HIV-1 Integrase Associates with Human Mitochondrial Lysyl-tRNA Synthetase
Replication of human immunodeficiency virus type 1 (HIV-1) requires the packaging of tRNALys,3 from the host cell into the new viral particles. The GagPol viral polyprotein precursor associates with mitochondrial lysyl-tRNA synthetase (mLysRS) in a complex with tRNALys, an essential step to initiate reverse transcription in the virions. The C-terminal integrase moiety of GagPol is essential for its association with mLysRS. We show that integrases from HIV-1 and HIV-2 bind mLysRS with the same efficiency. In this work, we have undertaken to probe the three-dimensional (3D) architecture of the complex of integrase with mLysRS. We first established that the C-terminal domain (CTD) of integrase is the major interacting domain with mLysRS. Using the pBpa-photo crosslinking approach, inter-protein cross-links were observed involving amino acid residues located at the surface of the catalytic domain of mLysRS and of the CTD of integrase. In parallel, using molecular docking simulation, a single structural model of complex was found to outscore other alternative conformations. Consistent with crosslinking experiments, this structural model was further probed experimentally. Five compensatory mutations in the two partners were successfully designed which supports the validity of the model. The complex highlights that binding of integrase could stabilize the tRNALys:mLysRS interaction.
Open AccessHow HIV-1 Integrase Associates with Human Mitochondrial Lysyl-tRNA Synthetase
Replication of human immunodeficiency virus type 1 (HIV-1) requires the packaging of tRNALys,3 from the host cell into the new viral particles. The GagPol viral polyprotein precursor associates with mitochondrial lysyl-tRNA synthetase (mLysRS) in a complex with tRNALys, an essential step to initiate reverse transcription in the virions. The C-terminal integrase moiety of GagPol is essential for its association with mLysRS. We show that integrases from HIV-1 and HIV-2 bind mLysRS with the same efficiency. In this work, we have undertaken to probe the three-dimensional (3D) architecture of the complex of integrase with mLysRS. We first established that the C-terminal domain (CTD) of integrase is the major interacting domain with mLysRS. Using the pBpa-photo crosslinking approach, inter-protein cross-links were observed involving amino acid residues located at the surface of the catalytic domain of mLysRS and of the CTD of integrase. In parallel, using molecular docking simulation, a single structural model of complex was found to outscore other alternative conformations. Consistent with crosslinking experiments, this structural model was further probed experimentally. Five compensatory mutations in the two partners were successfully designed which supports the validity of the model. The complex highlights that binding of integrase could stabilize the tRNALys:mLysRS interaction.
- Open Access
- 18 May 2018
- Published by Wiley in The FEBS Journal
- Vol. 285 (14) , 2654-2661
Mutations in MARS identified in a specific type of pulmonary alveolar proteinosis alter methionyl‐tRNA synthetase activity
Biallelic missense mutations in MARS are responsible for rare but severe cases of pulmonary alveolar proteinosis (PAP) prevalent on the island of La Réunion. MARS encodes cytosolic methionyl‐tRNA synthetase (MetRS), an essential translation factor. The multisystemic effects observed in patients with this form of PAP are consistent with a loss‐of‐function defect in an ubiquitously expressed enzyme. The pathophysiological mechanisms involved in MARS‐related PAP are currently unknown. In this work, we analyzed the effect of the PAP‐related mutations in MARS on the thermal stability and on the catalytic parameters of the MetRS mutants, relative to wild‐type. The effect of these mutations on the structural integrity of the enzyme as a member of the cytosolic multisynthetase complex was also investigated. Our results establish that the PAP‐related substitutions in MetRS impact the tRNAMet‐aminoacylation reaction especially at the level of methionine recognition, and suggest a direct link between the loss of activity of the enzyme and the pathological disorders in PAP.
- 18 May 2018
- Published by Wiley in The FEBS Journal
- Vol. 285 (14) , 2654-2661
Open AccessMutations in MARS identified in a specific type of pulmonary alveolar proteinosis alter methionyl‐tRNA synthetase activity
Biallelic missense mutations in MARS are responsible for rare but severe cases of pulmonary alveolar proteinosis (PAP) prevalent on the island of La Réunion. MARS encodes cytosolic methionyl‐tRNA synthetase (MetRS), an essential translation factor. The multisystemic effects observed in patients with this form of PAP are consistent with a loss‐of‐function defect in an ubiquitously expressed enzyme. The pathophysiological mechanisms involved in MARS‐related PAP are currently unknown. In this work, we analyzed the effect of the PAP‐related mutations in MARS on the thermal stability and on the catalytic parameters of the MetRS mutants, relative to wild‐type. The effect of these mutations on the structural integrity of the enzyme as a member of the cytosolic multisynthetase complex was also investigated. Our results establish that the PAP‐related substitutions in MetRS impact the tRNAMet‐aminoacylation reaction especially at the level of methionine recognition, and suggest a direct link between the loss of activity of the enzyme and the pathological disorders in PAP.
- Open Access
- 21 March 2018
- Published by Springer Nature in BMC Biochemistry
- Vol. 19 (1) , 2
Characterization of association of human mitochondrial lysyl-tRNA synthetase with HIV-1 Pol and tRNA3Lys
An important step in human immunodeficiency virus type 1 (HIV-1) replication is the packaging of tRNA3Lys from the host cell, which plays the role of primer RNA in the process of initiation of reverse transcription. The viral GagPol polyprotein precursor, and the human mitochondrial lysyl-tRNA synthetase (mLysRS) from the host cell, have been proposed to be involved in the packaging process. More specifically, the catalytic domain of mLysRS is supposed to interact with the transframe (TF or p6*) and integrase (IN) domains of the Pol region of the GagPol polyprotein. In this work, we report a quantitative characterization of the protein:protein interactions between mLysRS and its viral partners, the Pol polyprotein, and the isolated integrase and transframe domains of Pol. A dissociation constant of 1.3 ± 0.2 nM was determined for the Pol:mLysRS interaction, which exemplifies the robustness of this association. The protease and reverse transcriptase domains of GagPol are dispensable in this association, but the TF and IN domains have to be connected by a linker polypeptide to recapitulate a high affinity partner for mLysRS. The binding of the viral proteins to mLysRS does not dramatically enhance the binding affinity of mLysRS for tRNA3Lys. These data support the conclusion that the complex formed between GagPol, mLysRS and tRNA3Lys, which involves direct interactions between the IN and TF domains of Pol with mLysRS, is more robust than suggested by the previous models supposed to be involved in the packaging of tRNA3Lys into HIV-1 particles.
- 21 March 2018
- Published by Springer Nature in BMC Biochemistry
- Vol. 19 (1) , 2
Open AccessCharacterization of association of human mitochondrial lysyl-tRNA synthetase with HIV-1 Pol and tRNA3Lys
An important step in human immunodeficiency virus type 1 (HIV-1) replication is the packaging of tRNA3Lys from the host cell, which plays the role of primer RNA in the process of initiation of reverse transcription. The viral GagPol polyprotein precursor, and the human mitochondrial lysyl-tRNA synthetase (mLysRS) from the host cell, have been proposed to be involved in the packaging process. More specifically, the catalytic domain of mLysRS is supposed to interact with the transframe (TF or p6*) and integrase (IN) domains of the Pol region of the GagPol polyprotein. In this work, we report a quantitative characterization of the protein:protein interactions between mLysRS and its viral partners, the Pol polyprotein, and the isolated integrase and transframe domains of Pol. A dissociation constant of 1.3 ± 0.2 nM was determined for the Pol:mLysRS interaction, which exemplifies the robustness of this association. The protease and reverse transcriptase domains of GagPol are dispensable in this association, but the TF and IN domains have to be connected by a linker polypeptide to recapitulate a high affinity partner for mLysRS. The binding of the viral proteins to mLysRS does not dramatically enhance the binding affinity of mLysRS for tRNA3Lys. These data support the conclusion that the complex formed between GagPol, mLysRS and tRNA3Lys, which involves direct interactions between the IN and TF domains of Pol with mLysRS, is more robust than suggested by the previous models supposed to be involved in the packaging of tRNA3Lys into HIV-1 particles.
- 8 March 2017
- Published by Springer Nature
- Vol. 83, 505-522
The Aminoacyl-tRNA Synthetase Complex
Aminoacyl-tRNA synthetases (AARSs) are essential enzymes that specifically aminoacylate one tRNA molecule by the cognate amino acid. They are a family of twenty enzymes, one for each amino acid. By coupling an amino acid to a specific RNA triplet, the anticodon, they are responsible for interpretation of the genetic code. In addition to this translational, canonical role, several aminoacyl-tRNA synthetases also fulfill nontranslational, moonlighting functions. In mammals, nine synthetases, those specific for amino acids Arg, Asp, Gln, Glu, Ile, Leu, Lys, Met and Pro, associate into a multi-aminoacyl-tRNA synthetase complex, an association which is believed to play a key role in the cellular organization of translation, but also in the regulation of the translational and nontranslational functions of these enzymes. Because the balance between their alternative functions rests on the assembly and disassembly of this supramolecular entity, it is essential to get precise insight into the structural organization of this complex. The high-resolution 3D-structure of the native particle, with a molecular weight of about 1.5 MDa, is not yet known. Low-resolution structures of the multi-aminoacyl-tRNA synthetase complex, as determined by cryo-EM or SAXS, have been reported. High-resolution data have been reported for individual enzymes of the complex, or for small subcomplexes. This review aims to present a critical view of our present knowledge of the aminoacyl-tRNA synthetase complex in 3D. These preliminary data shed some light on the mechanisms responsible for the balance between the translational and nontranslational functions of some of its components.
- 8 March 2017
- Published by Springer Nature
- Vol. 83, 505-522
The Aminoacyl-tRNA Synthetase Complex
Aminoacyl-tRNA synthetases (AARSs) are essential enzymes that specifically aminoacylate one tRNA molecule by the cognate amino acid. They are a family of twenty enzymes, one for each amino acid. By coupling an amino acid to a specific RNA triplet, the anticodon, they are responsible for interpretation of the genetic code. In addition to this translational, canonical role, several aminoacyl-tRNA synthetases also fulfill nontranslational, moonlighting functions. In mammals, nine synthetases, those specific for amino acids Arg, Asp, Gln, Glu, Ile, Leu, Lys, Met and Pro, associate into a multi-aminoacyl-tRNA synthetase complex, an association which is believed to play a key role in the cellular organization of translation, but also in the regulation of the translational and nontranslational functions of these enzymes. Because the balance between their alternative functions rests on the assembly and disassembly of this supramolecular entity, it is essential to get precise insight into the structural organization of this complex. The high-resolution 3D-structure of the native particle, with a molecular weight of about 1.5 MDa, is not yet known. Low-resolution structures of the multi-aminoacyl-tRNA synthetase complex, as determined by cryo-EM or SAXS, have been reported. High-resolution data have been reported for individual enzymes of the complex, or for small subcomplexes. This review aims to present a critical view of our present knowledge of the aminoacyl-tRNA synthetase complex in 3D. These preliminary data shed some light on the mechanisms responsible for the balance between the translational and nontranslational functions of some of its components.
- Open Access
- 27 April 2016
- Published by Wiley in FEBS Open Bio
- Vol. 6 (7) , 696-706
Identification of protein interfaces within the multi‐aminoacyl‐tRNA synthetase complex: the case of lysyl‐tRNA synthetase and the scaffold protein p38
Human cytoplasmic lysyl‐tRNA synthetase (LysRS) is associated within a multi‐aminoacyl‐tRNA synthetase complex (MSC). Within this complex, the p38 component is the scaffold protein that binds the catalytic domain of LysRS via its N‐terminal region. In addition to its translational function when associated to the MSC, LysRS is also recruited in nontranslational roles after dissociation from the MSC. The balance between its MSC‐associated and MSC‐dissociated states is essential to regulate the functions of LysRS in cellular homeostasis. With the aim of understanding the rules that govern association of LysRS in the MSC, we analyzed the protein interfaces between LysRS and the full‐length version of p38, the scaffold protein of the MSC. In a previous study, the cocrystal structure of LysRS with a N‐terminal peptide of p38 was reported [Ofir‐Birin Y et al. (2013) Mol Cell 49, 30–42]. In order to identify amino acid residues involved in interaction of the two proteins, the non‐natural, photo‐cross‐linkable amino acid p‐benzoyl‐l‐phenylalanine (Bpa) was incorporated at 27 discrete positions within the catalytic domain of LysRS. Among the 27 distinct LysRS mutants, only those with Bpa inserted in place of Lys356 or His364 were cross‐linked with p38. Using mass spectrometry, we unambiguously identified the protein interface of the cross‐linked complex and showed that Lys356 and His364 of LysRS interact with the peptide from Pro8 to Arg26 in native p38, in agreement with the published cocrystal structure. This interface, which in LysRS is located on the opposite side of the dimer to the site of interaction with its tRNA substrate, defines the core region of the MSC. The residues identified herein in human LysRS are not conserved in yeast LysRS, an enzyme that does not associate within the MSC, and contrast with the residues proposed to be essential for LysRS:p38 association in the earlier work.
- 27 April 2016
- Published by Wiley in FEBS Open Bio
- Vol. 6 (7) , 696-706
Open AccessIdentification of protein interfaces within the multi‐aminoacyl‐tRNA synthetase complex: the case of lysyl‐tRNA synthetase and the scaffold protein p38
Human cytoplasmic lysyl‐tRNA synthetase (LysRS) is associated within a multi‐aminoacyl‐tRNA synthetase complex (MSC). Within this complex, the p38 component is the scaffold protein that binds the catalytic domain of LysRS via its N‐terminal region. In addition to its translational function when associated to the MSC, LysRS is also recruited in nontranslational roles after dissociation from the MSC. The balance between its MSC‐associated and MSC‐dissociated states is essential to regulate the functions of LysRS in cellular homeostasis. With the aim of understanding the rules that govern association of LysRS in the MSC, we analyzed the protein interfaces between LysRS and the full‐length version of p38, the scaffold protein of the MSC. In a previous study, the cocrystal structure of LysRS with a N‐terminal peptide of p38 was reported [Ofir‐Birin Y et al. (2013) Mol Cell 49, 30–42]. In order to identify amino acid residues involved in interaction of the two proteins, the non‐natural, photo‐cross‐linkable amino acid p‐benzoyl‐l‐phenylalanine (Bpa) was incorporated at 27 discrete positions within the catalytic domain of LysRS. Among the 27 distinct LysRS mutants, only those with Bpa inserted in place of Lys356 or His364 were cross‐linked with p38. Using mass spectrometry, we unambiguously identified the protein interface of the cross‐linked complex and showed that Lys356 and His364 of LysRS interact with the peptide from Pro8 to Arg26 in native p38, in agreement with the published cocrystal structure. This interface, which in LysRS is located on the opposite side of the dimer to the site of interaction with its tRNA substrate, defines the core region of the MSC. The residues identified herein in human LysRS are not conserved in yeast LysRS, an enzyme that does not associate within the MSC, and contrast with the residues proposed to be essential for LysRS:p38 association in the earlier work.
- Open Access
- 5 March 2016
- Published by Elsevier in Biochimie Open
- Vol. 2, 52-61
Association of human mitochondrial lysyl-tRNA synthetase with HIV-1 GagPol does not require other viral proteins
- 5 March 2016
- Published by Elsevier in Biochimie Open
- Vol. 2, 52-61
Open AccessAssociation of human mitochondrial lysyl-tRNA synthetase with HIV-1 GagPol does not require other viral proteins
- Open Access
- 2 August 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (32) , 28476-28487
Caenorhabditis elegans Evolves a New Architecture for the Multi-aminoacyl-tRNA Synthetase Complex
- 2 August 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (32) , 28476-28487
Open AccessCaenorhabditis elegans Evolves a New Architecture for the Multi-aminoacyl-tRNA Synthetase Complex
- 23 September 2009
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 48 (42) , 9959-9968
Translation Initiation from Two In-Frame AUGs Generates Mitochondrial and Cytoplasmic Forms of the p43 Component of the Multisynthetase Complex
In humans, nine aminoacyl-tRNA synthetases form a stable multiprotein complex with the three auxiliary proteins p18, p38, and p43. The N-terminal moiety of p43 is involved in its anchoring to the complex, and its C-terminal moiety has a potent tRNA binding capacity. The p43 component of the complex is also the precursor of p43(ARF), an apoptosis-released factor, and of p43(EMAPII), the endothelial-monocyte activating polypeptide II. Here we identified a new translation product of the gene of p43, which contains nine additional N-terminal amino acid residues. This gene product is targeted to the mitochondria and accounts for 2% of p43 expressed in human cells. The cytoplasmic and mitochondrial species of p43 are produced from the same mRNA by a mechanism of leaky scanning of the AUG codon at position −27, which is in an unfavorable sequence context for translation initiation. The finding that a mitochondrial species of p43 exists in human cells further exemplifies the multifaceted implications of p43 and opens new perspectives for the understanding of the role of p43 in the apoptotic cell.
- 23 September 2009
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 48 (42) , 9959-9968
Translation Initiation from Two In-Frame AUGs Generates Mitochondrial and Cytoplasmic Forms of the p43 Component of the Multisynthetase Complex
In humans, nine aminoacyl-tRNA synthetases form a stable multiprotein complex with the three auxiliary proteins p18, p38, and p43. The N-terminal moiety of p43 is involved in its anchoring to the complex, and its C-terminal moiety has a potent tRNA binding capacity. The p43 component of the complex is also the precursor of p43(ARF), an apoptosis-released factor, and of p43(EMAPII), the endothelial-monocyte activating polypeptide II. Here we identified a new translation product of the gene of p43, which contains nine additional N-terminal amino acid residues. This gene product is targeted to the mitochondria and accounts for 2% of p43 expressed in human cells. The cytoplasmic and mitochondrial species of p43 are produced from the same mRNA by a mechanism of leaky scanning of the AUG codon at position −27, which is in an unfavorable sequence context for translation initiation. The finding that a mitochondrial species of p43 exists in human cells further exemplifies the multifaceted implications of p43 and opens new perspectives for the understanding of the role of p43 in the apoptotic cell.